30-Mar-2026
Pulse Biosciences Grants RSUs to Chief Technology Officer
TipRanks (Fri, 27-Mar 5:43 PM ET)
Business Wire (Tue, 17-Mar 7:00 AM ET)
Business Wire (Thu, 12-Mar 7:00 AM ET)
Business Wire (Mon, 9-Mar 7:00 AM ET)
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Business Wire (Thu, 5-Mar 7:00 AM ET)
Market Chameleon (Wed, 4-Mar 3:17 AM ET)
Business Wire (Wed, 4-Mar 7:00 AM ET)
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Fri, 20-Feb 4:05 PM ET)
Pulse Biosciences Set to Spotlight Nanosecond Pulsed Field Ablation at Major Healthcare Conference
Market Chameleon (Fri, 20-Feb 3:39 AM ET)
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
Business Wire (Fri, 20-Feb 7:00 AM ET)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Pulse Biosciences trades on the NASDAQ stock market under the symbol PLSE.
As of March 30, 2026, PLSE stock price declined to $19.63 with 201,869 million shares trading.
PLSE has a beta of 0.67, meaning it tends to be less sensitive to market movements. PLSE has a correlation of 0.03 to the broad based SPY ETF.
PLSE has a market cap of $1.33 billion. This is considered a Small Cap stock.
Last quarter Pulse Biosciences reported $264,000 in Revenue and -$.26 earnings per share. This beat revenue expectation by $14,000 and missed earnings estimates by -$.01.
In the last 3 years, PLSE traded as high as $26.30 and as low as $2.36.
The top ETF exchange traded funds that PLSE belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
PLSE has outperformed the market in the last year with a return of +25.4%, while the SPY ETF gained +12.7%. In the last 3 month period, PLSE beat the market returning +36.3%, while SPY returned -8.2%. However, in the most recent 2 weeks PLSE has underperformed the stock market by returning -9.0%, while SPY returned -4.3%.
PLSE support price is $19.67 and resistance is $21.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSE shares will trade within this expected range on the day.